Anti-LRR70/ LRRC70/ SLRN monoclonal antibody

Anti-LRR70/ LRRC70/ SLRN antibody for FACS & in-vivo assay

Target products collectionGo to LRRC70/LRRC70 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0766-Ab-1/ GM-Tg-hg-MP0766-Ab-2Anti-Human LRRC70 monoclonal antibodyHuman
GM-Tg-rg-MP0766-Ab-1/ GM-Tg-rg-MP0766-Ab-2Anti-Rat LRRC70 monoclonal antibodyRat
GM-Tg-mg-MP0766-Ab-1/ GM-Tg-mg-MP0766-Ab-2Anti-Mouse LRRC70 monoclonal antibodyMouse
GM-Tg-cynog-MP0766-Ab-1/ GM-Tg-cynog-MP0766-Ab-2Anti-Cynomolgus/ Rhesus macaque LRRC70 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0766-Ab-1/ GM-Tg-felg-MP0766-Ab-2Anti-Feline LRRC70 monoclonal antibodyFeline
GM-Tg-cang-MP0766-Ab-1/ GM-Tg-cang-MP0766-Ab-2Anti-Canine LRRC70 monoclonal antibodyCanine
GM-Tg-bovg-MP0766-Ab-1/ GM-Tg-bovg-MP0766-Ab-2Anti-Bovine LRRC70 monoclonal antibodyBovine
GM-Tg-equg-MP0766-Ab-1/ GM-Tg-equg-MP0766-Ab-2Anti-Equine LRRC70 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0766-Ab-1/ GM-Tg-hg-MP0766-Ab-2; GM-Tg-rg-MP0766-Ab-1/ GM-Tg-rg-MP0766-Ab-2;
GM-Tg-mg-MP0766-Ab-1/ GM-Tg-mg-MP0766-Ab-2; GM-Tg-cynog-MP0766-Ab-1/ GM-Tg-cynog-MP0766-Ab-2;
GM-Tg-felg-MP0766-Ab-1/ GM-Tg-felg-MP0766-Ab-2; GM-Tg-cang-MP0766-Ab-1/ GM-Tg-cang-MP0766-Ab-2;
GM-Tg-bovg-MP0766-Ab-1/ GM-Tg-bovg-MP0766-Ab-2; GM-Tg-equg-MP0766-Ab-1/ GM-Tg-equg-MP0766-Ab-2
Products NameAnti-LRRC70 monoclonal antibody
Formatmab
Target NameLRRC70
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LRRC70 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species LRR70/ LRRC70/ SLRN VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0766
    Target NameLRRC70
    Gene ID100130733,113523645,120100696,100427296
    Gene Symbol and SynonymsLRRC70,SLRN
    Uniprot AccessionQ7Z2Q7
    Uniprot Entry NameLRR70_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000186105
    Target ClassificationN/A

    The target: LRRC70, gene name: LRRC70, also named as SLRN. Involved in positive regulation of response to cytokine stimulus. Is integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.